1939.3000 3.70 (0.19%)
NSE Oct 10, 2025 15:31 PM
Volume: 867.4K
 

1939.30
0.19%
Axis Direct
Glenmark's (GNP) Q4 PAT was below estimates due to significant miss in US sales (USD 150 mn vs. estimated USD 193 mn). The sales miss was led by lower gZetia sales (~USD 50 mn vs. est. ~USD 80 mn) and ~15% price erosion in US base business.
Glenmark Pharmaceuti.. has an average target of 2144.00 from 5 brokers.
More from Glenmark Pharmaceuticals Ltd.
Recommended